GINKGO BIOWORKS HOLDINGS, INC. Equity Method Investments
GINKGO BIOWORKS HOLDINGS, INC. (DNA) had Equity Method Investments of $7.62 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2026-08-06
- 2026-06-30: Equity Method Investments $7.62M.
- 2025-12-31: Equity Method Investments $0.00.
- 2023-12-31: Equity Method Investments $0.00.
- 2023-09-30: Equity Method Investments $1.12M.
| Period end | Equity Method Investments |
|---|---|
| 2026-06-30 | $7.62M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-06 |
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 |
| 2023-09-30 | $1.12M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.12M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.19M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.54M 10-K · filed 2024-02-29 |
| 2022-09-30 | $4.13M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $6.91M 10-Q · filed 2022-08-15 |
| 2021-12-31 | $13.19M 10-K · filed 2023-03-13 |
| 2021-09-30 | $16.36M 10-Q · filed 2021-11-15 |
| 2020-12-31 | $28.92M 10-K · filed 2022-03-29 |